A detailed history of Savvy Advisors, Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Savvy Advisors, Inc. holds 1,804 shares of LLY stock, worth $1.5 Million. This represents 0.53% of its overall portfolio holdings.

Number of Shares
1,804
Previous 773 133.38%
Holding current value
$1.5 Million
Previous $602 Million 171.56%
% of portfolio
0.53%
Previous 0.35%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $747,340 - $937,220
1,031 Added 133.38%
1,804 $1.63 Billion
Q1 2024

May 13, 2024

BUY
$592.2 - $792.28 $159,301 - $213,123
269 Added 53.37%
773 $602 Million
Q4 2023

Feb 08, 2024

BUY
$525.19 - $619.13 $264,695 - $312,041
504 New
504 $294 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $788B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Savvy Advisors, Inc. Portfolio

Follow Savvy Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Savvy Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Savvy Advisors, Inc. with notifications on news.